Type 2 Diabetes Trial, Recruiting (NCT06319716)

Type 2 Diabetes Trial, Recruiting NCT06319716 Sponsor: NYU Langone Health Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06319716 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You identify yourself as Chinese American
You are 18 years of age or older
You have been diagnosed with Type 2 diabetes, and this is recorded in your medical records
You have seen a doctor for your Type 2 diabetes care at least once in the past 12 months
Your most recent blood sugar control test (called HbA1c) showed a result of 7% or higher
You are willing to watch short videos about managing Type 2 diabetes
You own a smartphone, or if you do not have one, you are willing and able to use a smartphone provided by the study

Who may not be able to join:

You are unable or unwilling to give your formal agreement to take part in the study
You have a vision or hearing problem that is not corrected and would make it hard for you to take part in the study (confirm with trial site)
You are not willing to accept being randomly assigned to a group in the study
You are currently pregnant, planning to become pregnant in the next 6 months, or become pregnant during the study
You are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lu Hu, PhD, NYU Langone Health

Phone: 646-501-3438

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06319716

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 646-501-3438

More information: https://clinicaltrials.gov/study/NCT06319716

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You identify yourself as Chinese American
You are 18 years of age or older
You have been diagnosed with Type 2 diabetes, and this is recorded in your medical records
You have seen a doctor for your Type 2 diabetes care at least once in the past 12 months
Your most recent blood sugar control test (called HbA1c) showed a result of 7% or higher
You are willing to watch short videos about managing Type 2 diabetes
You own a smartphone, or if you do not have one, you are willing and able to use a smartphone provided by the study

Who may not be able to join:

You are unable or unwilling to give your formal agreement to take part in the study
You have a vision or hearing problem that is not corrected and would make it hard for you to take part in the study (confirm with trial site)
You are not willing to accept being randomly assigned to a group in the study
You are currently pregnant, planning to become pregnant in the next 6 months, or become pregnant during the study
You are currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

29 December 2024

Est. completion

31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Hemoglobin A1c (HbA1c) Levels; Hemoglobin A1c (HbA1c) Levels; Hemoglobin A1c (HbA1c) Levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov